Commonwealth Equity Services’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
ACA
DCM
JT
Commonwealth Equity Services's DFTX Position: Q2 2026 in Review
Commonwealth Equity Services reduced its Definium Therapeutics (DFTX) stake by 7.8% in Q2 2026, selling an estimated $19.8K and leaving 9,450 shares worth $445K. The position accounts for ﹤0.01% of the portfolio, ranked #3414.
Commonwealth Equity Services first reported a position in DFTX in Q2 2021 and has held it in 18 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.
- Commonwealth Equity Services held 9,450 shares of Definium Therapeutics worth $445K as of Q2 2026.
- Commonwealth Equity Services sold 801 Definium Therapeutics shares in Q2 2026, an estimated $19.8K.
- Definium Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3414 holding.
- Commonwealth Equity Services first reported a position in Definium Therapeutics in Q2 2021 and has held it in 18 quarters since.
- 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.